Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. [electronic resource]

By: Contributor(s): Producer: 20180829Description: 209-215 p. digitalISSN:
  • 1177-8881
Subject(s): Online resources: In: Drug design, development and therapy vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.